C

Cooper University Health Care | Internal Medicine Department

Research site

(Unclaimed)

Location

1 Cooper Plaza, Camden, New Jersey, United States of America

Site insights

Top conditions

Top treatments

Heparin

NSAID

Fentanyl Citrate

Budigalimab

Ketamine Hydrochloride

Lidocaine

ABBV-382

Bevacizumab

Acetaminophen

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 23 total trials

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (ATTACC-CAP)

This is an international, open-label, stratified randomized controlled trial with Bayesian adaptive stopping rules to compare the effects of therapeu...

Enrolling

Community-acquired Pneumonia

Drug: Heparin

Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the Evaluation and Management of Females With Chronic Bladder Pain and Cystitis-like Symptoms

Real-world clinical practice multicenter study to determine the clinical implications of employing PCR/NGS technology to identify and treat potential...

Enrolling

Interstitial Cystitis

Bladder Pain Syndrome

Diagnostic Test: Polymerase Chain Reaction and Next-Generation DNA Sequencing

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects (FLAMINGO-01)

This is a prospective, randomized, double-blinded, placebo-controlled, multi-center, Phase 3 study of GLSI-100 immunotherapy in HLA-A\*02 positive an...

Enrolling

Breast Cancer

Biological: Placebo

Biological: GLSI-100